LOXL1 and LOXL4 are novel target genes of the Zn2+-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cells. This evidence concerns the gene LOXL1 and triple-negative breast carcinoma.